Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03039634 · ClinicalTrials.gov registry record
Long-term Follow-up Study of Subjects Who Completed Clinical Studies 755.1100_FA, 810.1100_FA, or 1064.1100_FA
A clinical trial of Acne Vulgaris, sponsored by Sienna Labs.
- Completed
- Registry status
- 76
- Enrollment target
- 16
- Study locations
NCT03039634: Completed study of Acne Vulgaris, sponsored by Sienna Labs.
NCT03039634 is a study of Acne Vulgaris that has completed, run by Sienna Labs. The registered enrollment target is 76 participants, below the 274-participant average among 67 other Acne Vulgaris trials with a reported enrollment target (72% lower). The trial reports 16 study locations across 13 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03039634, a study of Acne Vulgaris, has completed, sponsored by Sienna Labs.
- COMPLETED
- Registry status
- 76 participants
- Enrollment target
- 16
- Study locations
Study Summary
This study evaluates the safety, effectiveness, and maintenance of effect of a novel topical silver particle solution (Sienna 755.1100, 810.1100, or 1064.1100) used in conjunction with a laser for the treatment of Acne Vulgaris.
Primary Outcome
Maintenance of effect by comparing lesion counts conducted at the exit visit of the predecessor study (ie, 12 weeks post-final treatment) and visit 2 of this study (ie, 18 weeks post-final treatment).
Conditions Studied
Study Locations (16)
Texas
- - Houston
- - Pflugerville
- - San Antonio
Florida
- - Coral Gables
- - Miami
Arizona
- - Scottsdale
California
- - Santa Monica
Maryland
- - Hunt Valley
Massachusetts
- - Beverly
Missouri
- - St Louis
New Jersey
- - Hackensack
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2016-08 |
| Est. Completion | 2018-05 |
What the finished NCT03039634 record still lists
NCT03039634 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 76 participants, a relatively small participant target, below the 274-participant average among 67 other Acne Vulgaris trials with a reported enrollment target (72% lower).
The record links to 1 condition, with Acne Vulgaris appearing as the primary indexed condition, and to 0 interventions.
NCT03039634 lists 16 locations in 13 states (Texas, Florida, Arizona).
Frequently Asked Questions
What is clinical trial NCT03039634 about?
NCT03039634 is a clinical study titled "Long-term Follow-up Study of Subjects Who Completed Clinical Studies 755.1100_FA, 810.1100_FA, or 1064.1100_FA". This study evaluates the safety, effectiveness, and maintenance of effect of a novel topical silver particle solution (Sienna 755.1100, 810.1100, or 1064.1100) used in conjunction with a laser for the treatment of Acne Vulgaris.
What is the current status of trial NCT03039634?
This trial is currently completed. The enrollment target is 76 participants. The study started on 2016-08. Estimated completion is 2018-05.
What conditions does trial NCT03039634 study?
This clinical trial studies the following conditions: Acne Vulgaris.
Who is sponsoring clinical trial NCT03039634?
This trial is sponsored by Sienna Labs, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03039634 being conducted?
This trial has 16 study locations across Arizona, California, Florida, Maryland, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acne Vulgaris
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03039634's enrollment target sits among peer trials
76 40th of 67 higher than 28 of 67 other Acne Vulgaris trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acne Vulgaris trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Weekly Isotretinoin vs Tetracycline for Moderate Acne
RECRUITING · Early Phase 1
-
Clascoterone for Steroid-related Acne Vulgaris in Transgender Male Patients Receiving Masculinizing Hormone Therapy
RECRUITING · Phase 1
-
Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Moderate to Severe Acne Vulgaris With Photodynamic Therapy in Adults
ACTIVE NOT RECRUITING · Phase 2
-
Laser Treatment of Moderate to Severe Acne Vulgaris
ACTIVE NOT RECRUITING · NA
-
A Study to Assess Sebaceous Gland Changes and Constituents of Sebum (Skin Oil) Induced by Clascoterone 1% Cream in Acne Patients
ACTIVE NOT RECRUITING · Phase 4
-
A Post Market Device Study for the Treatment of Acne
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02615184 · 76 participants · Phase 2
A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old
- NCT02821741 · 76 participants · NA
Effects of External Ear Stimulation on Pain Perception and Mood
- NCT03019757 · 76 participants
Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
- NCT03353584 · 76 participants · NA
Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia